The latest information regarding the BioCanRx research network and biotherapeutic research.
View this email in your browser
research funding, cancer research funding, cancer funding
   BioCanRx rolling, open call for funding
   Deadline: November 9, 2016

   Other funding opportunities currently available:

   Canadian Cancer Society: Knowledge to Action Grants
    Deadline: February 1, 2017

   Prostate Cancer Canada: Movember Discovery Grants
   Deadline: TBC

Helping scientists do science better, one failure at a time
By Brad McKay
Most of us have probably heard the saying “Failure is life’s greatest teacher” at one point in our life, but few of us have taken this time-honoured maxim to heart more than Dr. Jonathan Kimmelman. In fact, you might even say that his life’s work depends on it.    

Dr. Kimmelman, the lead investigator on a new project that is exploring failure rates in Canadian cancer research, is studying the complex decision-making process that researchers make on their path to developing new cancer drugs.

Jonathan Kimmelman

Dr. Jonathan Kimmelman
Lowering barriers for learning
BioCanRx HQP Travel Awards and Lab Exchanges enable HQP to access external opportunities not offered by the network. Travel Awards reimburse eligible HQP for a maximum of $1000 CAD and Lab Exchanges reimburse up to $3000 CAD.
Visit our website to learn more about these opportunities! 

Special Travel Awards to the Pan-Canadian Strategic Forum on Cell & Gene Therapy
BioCanRx is partnering with CellCAN and the Centre for Commercialization of Cancer Immunotherapy (C3i) on a national forum on the future of cell and gene therapy. The Pan-Canadian Strategic Forum on Cell & Gene Therapy is taking place in Montreal on March 9-10, 2017.
BioCanRx is offering 15 HQP Travel Awards (reimbursement up to $750 CAD) to attend this exciting event that will bring together national and international experts in cell and gene therapy. Learn more about the event and our travel awards on CellCAN’s event website (Application period between November 7 to 30, 2016).

Learn about professional skills through the SMRTS Program!
SMRTS stands for Sharing Multi-network Resources for Trainee Success, and it is joint collaboration between nine Networks of Centres of Excellences and other non-profit organizations. The first webinar in this FREE WEBINAR SERIES took place on October 26, 2016 and was presented by AGE-WELL: Canada's technology and aging network on Reverse Innovation.
The next free webinar is taking place on Thursday, November 17, 2016 from 1:00 pm to 2:00 pm (EST). Allergen: the Allergy, Genes and Environment Network will present on Communicating in Plain Language.
Register here!

You can find more information about training, education and career opportunities at the BioCanRx Training website.

This past summer, BioCanRx accepted its inaugural cohort of undergraduate students into theBioCanRx Summer Studentship Program. This program provides funding for network investigators to recruit talented university and college students onto exciting cancer biotherapeutics research projects. The competitive application process ensured that the awarded studentships would provide a practical, hands-on research experience that would inspire the next generation of highly qualified personnel.

Learn more about this year’s students and their BioCanRx Summer Studentship experiences!
cancer summit, cancer conference
Summit4CI HQP Working Group
BioCanRx is seeking eight HQP to participate on the Summit4CI HQP Working Group from December 2016 to June 2017. This group will advise, organize and execute the training activities at the 2017 Summit4CI in the National Capital Region from June 25-28, 2017.
Learn more about this volunteer opportunity with BioCanRx!

Other upcoming events and opportunities:

Innovative approaches to optimal cancer care in Canada
CPAC | April 7-8, 2017

Science Odyssey - Ten days of discovery and innovation
May 12 to 21, 2017
Network members: Feature your research here by sending us a link to your recent publication!
Turnstone Biologics secures US$41.4 million to advance cancer immunotherapy
The Ottawa Hospital | November 2, 2016

Canadian Cancer Society and Canadian Breast Cancer Foundation plan to merge
CCS | October 28, 2016

FDA fast tracks approval for soft tissue sarcoma antibody therapy
Reuters | October 20, 2016

FDA approves cancer immunotherapy for specific type of metastatic lung cancer
Business Wire | October 18, 2016

30th edition of Canadian Cancer Statistics
Canadian Cancer Society | October 18, 2016

Robotic cells that could seek out tumours
Cell | October 6, 2016

Scientists cautious about fighting cancer with immunotherapy
StatNews | September 25, 2016

Government of Canada invests significant funds in big data research
Genome Canada | September 13, 2016
Copyright © BioCanRx, All rights reserved.

Be a part of the BioCanRx community! Please send news and information to:
Amanda Devost, Manager, Communication and Corporate Affairs, BioCanRx

Our mailing address is:
501 Smyth Road, Box 611, Ottawa, Ontario K1H 8L6

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
BioCanRx · 501 Smyth Road, Box 611 · Ottawa, On K1H 8L6 · Canada

Email Marketing Powered by Mailchimp